Cited by 75

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Incensole Acetate, a Novel Anti-Inflammatory Compound Isolated from Boswellia Resin, Inhibits Nuclear Factor-κB Activation

Moussaieff, Arieh, Shohami, Esther, Kashman, Yoel, Fride, Ester, Schmitz, M. Lienhard, Renner, Florian, Fiebich, Bernd L., Munoz, Eduardo, Ben-Neriah, Yinon, Mechoulam, Raphael·2007·Molecular Pharmacology

Abstract

Boswellia resin is a major anti-inflammatory agent in herbal medical tradition, as well as a common food supplement. Its anti-inflammatory activity has been attributed to boswellic acid and its derivatives. Here, we re-examined the anti-inflammatory effect of the resin, using inhibitor of nuclear factor-kappaB alpha (IkappaB alpha) degradation in tumor necrosis factor (TNF) alpha-stimulated HeLa cells for a bioassay-guided fractionation. We thus isolated two novel nuclear factor-kappaB (NF-kappaB) inhibitors from the resin, their structures elucidated as incensole acetate (IA) and its nonacetylated form, incensole (IN). IA inhibited TAK/TAB-mediated IkappaB kinase (IKK) activation loop phosphorylation, resulting in the inhibition of cytokine and lipopolysaccharide-mediated NF-kappaB activation. It had no effect on IKK activity in vitro, and it did not suppress IkappaB alpha phosphorylation in costimulated T-cells, indicating that the kinase inhibition is neither direct nor does it affect all NF-kappaB activation pathways. The inhibitory effect seems specific; IA did not interfere with TNFalpha-induced activation of c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein kinase. IA treatment had a robust anti-inflammatory effect in a mouse inflamed paw model. Cembrenoid diterpenoids, specifically IA and its derivatives, may thus constitute a potential novel group of NF-kappaB inhibitors, originating from an ancient anti-inflammatory herbal remedy.

Overview

Integrity signals

Registry

Crossref · 10.1124/mol.107.038810

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Show all 1 references

Research works printed but not linked: 37

  1. Ahn, 2007, Embelin, an inhibitor of X chromosome-linked inhibitor-of-apoptosis protein, blocks nuclear factor-κB (NF-κB) signaling pathway leading to suppression of NF-κB-regulated antiapoptotic and metastatic gene products, Mol Pharmacol, 71, 209, 10.1124/mol.106.028787 · DOI
  2. Altmann, 2004, Coupling of boswellic acid-induced Ca2+ mobilisation and MAPK activation to lipid metabolism and peroxide formation in human leucocytes, Br J Pharmacol, 141, 223, 10.1038/sj.bjp.0705604 · DOI
  3. Ben-Neriah, 2004, Of mice and men, EMBO Rep, 5, 668, 10.1038/sj.embor.7400187 · DOI
  4. Blonska, 2005, TAK1 is recruited to the tumor necrosis factor-α (TNF-α) receptor 1 complex in a receptor-interacting protein (RIP)-dependent manner and cooperates with MEKK3 leading to NF-κB activation, J Biol Chem, 280, 43056, 10.1074/jbc.M507807200 · DOI
  5. Bradford, 1976, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal Biochem, 72, 248, 10.1016/0003-2697(76)90527-3 · DOI · Paper page
  6. Bremner, 2002, Natural products as targeted modulators of the nuclear factor-kappaB pathway, J Pharm Pharmacol, 54, 453, 10.1211/0022357021778637 · DOI
  7. Calhoun, 1987, Effect of selected antiinflammatory agents and other drugs on zymosan, arachidonic acid, PAF and carrageenan induced paw edema in the mouse, Agents Actions, 21, 306, 10.1007/BF01966499 · DOI
  8. Calzado, 2007, NF-kappaB inhibitors for the treatment of inflammatory diseases and cancer, Curr Med Chem, 14, 367, 10.2174/092986707779941113 · DOI
  9. Castrillo, 2001, Inhibition of the nuclear factor κB (NF-κB) pathway by tetracyclic kaurene diterpenes in macrophages. Specific effects on NF-κB-inducing kinase activity and on the coordinate activation of ERK and p38 MAPK, J Biol Chem, 276, 15854, 10.1074/jbc.M100010200 · DOI
  10. Corsano, 1967, The structure of incensole, Tetrahedron, 23, 1977, 10.1016/S0040-4020(01)82601-6 · DOI
  11. English, 1974, Single-step separation of red blood cells. Granulocytes and mononuclear leukocytes on discontinuous density gradients of Ficoll-Hypaque, J Immunol Methods, 5, 249, 10.1016/0022-1759(74)90109-4 · DOI
  12. Gacs-Baitz, 1978, Carbon-13 nuclear magnetic resonance of some fourteen-membered macrocyclic diterpenes, J Chem Res (M), 4, 1701
  13. Gerhardt, 2001, Therapy of active Crohn disease with Boswellia serrata extract H 15, Z Gastroenterol, 39, 11, 10.1055/s-2001-10708 · DOI
  14. Gupta, 1998, Effects of Boswellia serrata gum resin in patients with bronchial asthma: results of a double-blind, placebo-controlled, 6-week clinical study, Eur J Med Res, 3, 511
  15. Häcker, 2006, Regulation and function of IKK and IKK-related kinases, Sci STKE, 2006, re13, 10.1126/stke.3572006re13 · DOI
  16. Hamm, 2005, A chemical investigation by headspace SPME and GC-MS of volatile and semi-volatile terpenes in various olibanum samples, Phytochemistry, 66, 1499, 10.1016/j.phytochem.2005.04.025 · DOI
  17. Hanson, 2005, Diterpenoids, Nat Prod Rep, 22, 594, 10.1039/b501834j · DOI
  18. Hong, 2007, Smad7 binds to the adaptors TAB2 and TAB3 to block recruitment of the kinase TAK1 to the adaptor TRAF2, Nat Immunol, 8, 504, 10.1038/ni1451 · DOI
  19. Kang, 2004, Cytosolic peroxiredoxin attenuates the activation of Jnk and p38 but potentiates that of Erk in Hela cells stimulated with tumor necrosis factor-α, J Biol Chem, 279, 2535, 10.1074/jbc.M307698200 · DOI
  20. Karin, 2000, Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity, Annu Rev Immunol, 18, 621, 10.1146/annurev.immunol.18.1.621 · DOI · Paper page
  21. Karin, 2005, Inflammation-activated protein kinases as targets for drug development, Proc Am Thorac Soc, 2, 386, 10.1513/pats.200504-034SR · DOI
  22. Khanna, 2007, Natural products as a gold mine for arthritis treatment, Curr Opin Pharmacol, 7, 344, 10.1016/j.coph.2007.03.002 · DOI
  23. Lawrence, 2001, Possible new role for NF-kappaB in the resolution of inflammation, Nat Med, 7, 1291, 10.1038/nm1201-1291 · DOI
  24. Leung, 2005, Novel mechanism of inhibition of nuclear factor-κB DNA-binding activity by diterpenoids isolated from Isodon rubescens, Mol Pharmacol, 68, 286, 10.1124/mol.105.012765 · DOI
  25. Mattioli, 2004, Transient and selective NF-kappa B p65 serine 536 phosphorylation induced by T cell costimulation is mediated by I kappa B kinase beta and controls the kinetics of p65 nuclear import, J Immunol, 172, 6336, 10.4049/jimmunol.172.10.6336 · DOI
  26. Moussaieff, 2005, The Jerusalem Balsam: from the Franciscan monastery in the old city of Jerusalem to Martindale 33, J Ethnopharmacol, 101, 16, 10.1016/j.jep.2005.03.028 · DOI
  27. Noble, 1968, Ficoll flotation for the separation of blood leukocyte types, Blood, 31, 66, 10.1182/blood.V31.1.66.66 · DOI
  28. Ojo-Amaize, 2002, Hypoestoxide, a natural nonmutagenic diterpenoid with antiangiogenic and antitumor activity: possible mechanisms of action, Cancer Res, 62, 4007
  29. Rizzo, 1996, Arachidonic acid mediates interleukin-1 and tumor necrosis factor-alpha-induced activation of the c-jun amino-terminal kinases in stromal cells, Blood, 88, 3792, 10.1182/blood.V88.10.3792.bloodjournal88103792 · DOI
  30. Sancho, 2004, Anti-HIV activity of some synthetic lignanolides and intermediates, Bioorg Med Chem Lett, 14, 4483, 10.1016/j.bmcl.2004.06.047 · DOI
  31. Siqueira-Junior, 2003, Effects of valeryl salicylate, a COX-1 inhibitor, on models of acute inflammation in mice, Pharmacol Res, 48, 437, 10.1016/S1043-6618(03)00188-9 · DOI
  32. Sizemore, 2002, Distinct roles of the IκB kinase α and β subunits in liberating nuclear factor κB (NF-κB) from IκB and in phosphorylating the p65 subunit of NF-kappa B, J Biol Chem, 277, 3863, 10.1074/jbc.M110572200 · DOI
  33. Tempeam, 2005, A new cytotoxic daphnane diterpenoid, rediocide G, from Trigonostemon reidioides, Chem Pharm Bull, 53, 1321, 10.1248/cpb.53.1321 · DOI
  34. Xia, 2005, Boswellic acid acetate induces apoptosis through caspase-mediated pathways in myeloid leukemia cells, Mol Cancer Ther, 4, 381, 10.1158/1535-7163.MCT-03-0266 · DOI
  35. Yang, 2003, IKK beta plays an essential role in the phosphorylation of RelA/p65 on serine 536 induced by lipopolysaccharide, J Immunol, 170, 5630, 10.4049/jimmunol.170.11.5630 · DOI
  36. Yinjun, 2005, Triptolide inhibits transcription factor NF-kappaB and induces apoptosis of multiple myeloma cells, Leuk Res, 29, 99, 10.1016/j.leukres.2004.05.014 · DOI
  37. Zhang, 2005, Cytotoxic diterpenoids from the soft coral Sinularia microclavata, J Nat Prod, 68, 1087, 10.1021/np058006v · DOI

Cited by

Sorted by citations

See all 75

Metadata

Authors
Moussaieff, A., Shohami, E., Kashman, Y., Fride, E., Schmitz, M. L., Renner, F., Fiebich, B. L., Munoz, E., Ben-Neriah, Y., & Mechoulam, R.
Venue
Molecular Pharmacology
Publisher
Elsevier BV
Published
2007-12
Volume
72
Issue
6
Pages
1657-1664
ISSN
0026-895X
Cited by
75
References
1
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review